Your browser version may not work well with NCBI's Web applications. More information here...
1: Br J Pharmacol. 1976 Apr;56(4):399-402.Click here to read Links

Lithium orotate, carbonate and chloride: pharmacokinetics, polyuria in rats.

Smith DF.

1 The pharmacokinetics of the lithium ion administered as lithium orotate were studied in rats. Parallel studies were carried out with lithium carbonate and lithium chloride. 2 No differences in the uptake, distribution and excretion of the lithium ion were observed between lithium orotate, lithium carbonate and lithium chloride after single intraperitoneal, subcutaneous or intragastric injections (0.5-1.0 mEq lithium/kg) or after administration of the lithium salts for 20 days in the food. 3 The findings oppose the notion that the pharmacokinetics of the lithium ion given as lithium orotate differ from lithium chloride or lithium carbonate. 4 Polyuria and polydipsia developed more slowly in rats given lithium orotate than in those given lithium carbonate or lithium chloride, perhaps due to an effect of the orotate anion.

PMID: 1260219 [PubMed - indexed for MEDLINE]

PMCID: PMC1666891

Patient Drug Information

  • Lithium (Eskalith CR® , Eskalith® , Lithobid® )

    Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of mania, and ...

  • Source: AHFS Consumer Medication Information